Stocks took a leg higher Friday afternoon on comments from the White House that President Donald Trump is “optimistic” China ...

Truist raised the firm’s price target on Elevance Health (ELV) to $510 from $480 and keeps a Buy rating on the shares as part of a broader ...

Futures turned higher as Treasury yields backed off worrisome levels. JPMorgan beat views. Two key inflation reports loom.

US Stock Market on March 12: The Dow Jones Industrial Average, the S&P 500 and the Nasdaq Composite indices eked out mild gains amid choppy trade on Wednesday, in some respite for Wall Street bulls ...

Shares of Elevance Health Inc. ELV rallied 1.11% to $435.68 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 9.52% to ...

This was the stock's second consecutive day of losses.

Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet ...

In its fourth quarter 2024 investor letter, River Road Large Cap Value Select Fund emphasized stocks such as Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is a health benefits ...

The second issue for Elevance is investor sentiment. A mentally deranged young man murdered a top executive of UnitedHealthcare, the largest health insurer ... of S&P Dow Jones Indices LLC ...

Wells Fargo analyst Stephen Baxter reiterated a Buy rating on Elevance Health (ELV – Research Report ... Baxter is a 3-star analyst with an average return of 1.7% and a 42.73% success rate.

The stock market didn’t go much of anywhere on Thursday. The Dow Jones Industrial Average dipped just 11 points. The S&P 500was down 0.2%. The Nasdaq Composite was down 0.3%. The yield on the 2 ...

Stay with Moneycontrol to get real time updates on US MARKET share price, top gainers, top losers and market insights. The US market indices concluded today's trading session with slight declines.